APA (7th ed.) Citation

Agelopoulos, K., Rülander, F., Dangelmaier, J., Lotts, T., Osada, N., Metze, D., . . . Ständer, S. (2019). Neurokinin 1 receptor antagonists exhibit peripheral effects in prurigo nodularis including reduced ERK1/2 activation. Journal of the European Academy of Dermatology and Venereology, 33(12), 2371-2379. https://doi.org/10.1111/jdv.15905

Chicago Style (17th ed.) Citation

Agelopoulos, K., F. Rülander, J. Dangelmaier, T. Lotts, N. Osada, D. Metze, T. A. Luger, K. Loser, and S. Ständer. "Neurokinin 1 Receptor Antagonists Exhibit Peripheral Effects in Prurigo Nodularis Including Reduced ERK1/2 Activation." Journal of the European Academy of Dermatology and Venereology 33, no. 12 (2019): 2371-2379. https://doi.org/10.1111/jdv.15905.

MLA (9th ed.) Citation

Agelopoulos, K., et al. "Neurokinin 1 Receptor Antagonists Exhibit Peripheral Effects in Prurigo Nodularis Including Reduced ERK1/2 Activation." Journal of the European Academy of Dermatology and Venereology, vol. 33, no. 12, 2019, pp. 2371-2379, https://doi.org/10.1111/jdv.15905.